Edition:
United States

Corbus Pharmaceuticals Holdings Inc (CRBP.OQ)

CRBP.OQ on NASDAQ Stock Exchange Global Market

6.51USD
14 Dec 2018
Change (% chg)

$-0.12 (-1.81%)
Prev Close
$6.63
Open
$6.55
Day's High
$6.63
Day's Low
$6.43
Volume
141,744
Avg. Vol
249,536
52-wk High
$9.85
52-wk Low
$4.53

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 1.09 -0.255
Jun '18 0.85 -0.211
Mar '18 0.95 -0.207
FY 2017 Dec '17 0.00 -0.199
Sep '17 0.80 -0.139
Jun '17 0.35 -0.145
Mar '17 1.29 -0.161
FY 2016 Dec '16 0.38 -0.171
Sep '16 0.74 -0.122
Jun '16 0.40 -0.108
Mar '16 0.40 -0.077
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-18 5 1.08 1.90 0.00 0.17
Quarter Ending Mar-19 4 1.17 1.90 0.00 --
Year Ending Dec-18 5 3.98 4.80 2.89 0.35
Year Ending Dec-19 7 5.32 12.50 0.00 0.00
Earnings (per share)
Quarter Ending Dec-18 5 -0.25 -0.20 -0.29 -0.11
Quarter Ending Mar-19 4 -0.24 -0.23 -0.26 --
Year Ending Dec-18 5 -0.93 -0.88 -0.97 -0.73
Year Ending Dec-19 7 -1.01 -0.85 -1.28 -0.81
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.71 34.39
P/E High - Last 5 Yrs. -- 148.17 46.24
P/E Low - Last 5 Yrs. -- 47.84 24.59
Beta -- 1.08 0.91
Price to Sales (TTM) 134.55 49.58 6.22
Price to Book (MRQ) 9.89 10.17 5.20
Price to Tangible Book (MRQ) 9.89 13.83 6.74
Price to Cash Flow (TTM) -- 52.85 24.17
% Owned Institutions 31.38 3.75 1.78

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.44
Dividend Yield - 5 Year Avg -- 0.09 1.46
Dividend 5 Year Growth Rate -- 0.79 4.94
Payout Ratio(TTM) -- 7.05 42.49

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -11.70 130.06 8.17
Sales (TTM) vs TTM 1 Yr. Ago 108.00 47.89 6.50
Sales - 5 Yr. Growth Rate -- 22.79 10.44
EPS (MRQ) vs Qtr. 1 Yr. Ago -34.45 75.90 23.09
EPS (TTM) vs TTM 1 Yr. Ago -89.47 -- --
EPS - 5 Yr. Growth Rate -- 12.04 10.49
Capital Spending - 5 Yr. Growth Rate -- 9.25 14.59

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.18 2.28
Current Ratio (MRQ) 6.37 3.44 3.10
LT Debt to Equity (MRQ) 0.00 18.69 11.49
Total Debt to Equity (MRQ) 0.10 31.36 16.03
Interest Coverage (TTM) -- -43.32 30.57

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.37 54.44
Gross Margin - 5 Yr. Avg. -- 60.62 52.36
EBITD Margin (TTM) -996.89 -- --
EBITD - 5 Yr. Avg -- -110.03 13.16
Operating Margin (TTM) -1,001.05 -185.03 6.07
Operating Margin - 5 Yr. Avg. -- -126.47 8.47
Pre-Tax Margin (TTM) -1,002.11 -175.80 7.02
Pre-Tax Margin - 5 Yr. Avg. -- -132.63 8.71
Net Profit Margin (TTM) -1,002.11 -182.53 3.12
Net Profit Margin - 5 Yr. Avg. -- -137.03 4.91
Effective Tax Rate (TTM) -- 21.47 23.26
Effective Tax Rate - 5 Yr. Avg. -- 15.43 23.83

Efficiency

  Company industry sector
Revenue/Employee (TTM) 110,485 7,648,872 873,051,409
Net Income/Employee (TTM) -1,107,175 653,324 103,483,755
Receivable Turnover (TTM) -- 6.25 5.80
Inventory Turnover (TTM) -- 1.89 3.56
Asset Turnover (TTM) 0.08 0.32 0.95

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -82.39 6.47 11.45
Return on Assets - 5 Yr. Avg. -- 5.54 12.50
Return on Investment (TTM) -100.08 9.01 14.96
Return on Investment - 5 Yr. Avg. -- 6.87 16.23
Return on Equity (TTM) -100.21 10.15 16.52
Return on Equity - 5 Yr. Avg. -- 8.40 17.37
  1 Year 3 Year 5 Year
Sales % 194.80 -- --
EPS (TTM) % -72.19 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Corbus Pharmaceuticals Holdings Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 9.63 5.85 99 98
13 Week 15.62 9.99 99 94
26 Week 2.78 -5.03 99 98
52 Week -15.04 -27.99 79 68
YTD -12.43 -23.09 65 72
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 46.07%
# of Holders: 112
Total Shares Held: 26,367,928
3 Mo. Net Change: 381,646
# New Positions: 13
# Closed Positions: 18
# Increased Positions: 50
# Reduced Positions: 50
# Net Buyers: 0
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.